Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence

被引:96
作者
Pannek, J [1 ]
Brands, FH [1 ]
Senge, T [1 ]
机构
[1] Ruhr Univ Bochum, Marienhosp Herne, Urol Klin, D-4690 Herne, Germany
关键词
urethra; urinary incontinence; stress; lymph nodes; injections;
D O I
10.1016/S0022-5347(05)65767-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose: Despite 20 years of experience with injectable bulking agents for stress urinary incontinence results are rather disappointing. The satisfying initial results of collagen injection are rapidly decreasing with time, whereas synthetic bulking agents have shown problems with migration and biocompatibility. The ideal bulking agent would be permanent with a good clinical long-term success rate. We report our experience with Durasphere (Carbon Medical Technologies, Inc., St. Paul, Minnesota), a new injectable bulking agent containing carbon coated beads. Materials and Methods: Seven men and 13 women with a mean age of 62.5 years underwent transurethral submucosal injection. The 13 female patients had been diagnosed with type III stress urinary incontinence and each had undergone at least 1 unsuccessful previous operation for urinary incontinence. There were iatrogenic and traumatic sphincter lesions in 6 and 1 of the male patients, respectively. Mean volume injected per treatment was 6.0 cc. Mean followup was 10 months. Results: After 6 months 76.9% of the female patients were improved but after 12 months the success rate decreased to 33%. In the male patients after 6 months the success rate was 66%, which decreased to 33% after 12 months. At the 6-month followup we observed significant migration of the carbon coated beads into the local and distant lymph nodes as well as into the urethral mucosa. Conclusions: Due to limited success and proved particle migration, carbon coated beads do not show any improvement over existing bulking materials. The clinical effect of bead migration must be determined before extended use of this substance.
引用
收藏
页码:1350 / 1353
页数:4
相关论文
共 20 条
[1]
AARANSON I, 1994, DIAL PEDIAT UROL, V17, P7
[2]
Results of transurethral injection of silicone micro-implants for females with intrinsic sphincter deficiency [J].
Barranger, E ;
Fritel, X ;
Kadoch, O ;
Liou, Y ;
Pigné, A .
JOURNAL OF UROLOGY, 2000, 164 (05) :1619-1622
[3]
BERG S, 1973, ARCH SURG-CHICAGO, V107, P379
[4]
Borgatti R, 1996, PEDIATRICS, V98, P290
[5]
COMPLETE URINARY OBSTRUCTION FOLLOWING PERIURETHRAL POLYTETRAFLUOROETHYLENE INJECTION FOR URINARY-INCONTINENCE [J].
BOYKIN, W ;
RODRIGUEZ, FR ;
BRIZZOLARA, JP ;
THOMPSON, IM ;
ZEIDMAN, EJ .
JOURNAL OF UROLOGY, 1989, 141 (05) :1199-1200
[6]
Calvosa C., 2000, European Urology, V37, P70
[7]
The use of polydimethylsiloxane in the treatment of incontinence after radical prostatectomy [J].
Colombo, T ;
Augustin, H ;
Breinl, E ;
Schips, L ;
Hubmer, G .
BRITISH JOURNAL OF UROLOGY, 1997, 80 (06) :923-926
[8]
Urinary stress incontinence due to intrinsic sphincteric deficiency: Experience with fat and collagen periurethral injections [J].
Haab, F ;
Zimmern, PE ;
Leach, GE .
JOURNAL OF UROLOGY, 1997, 157 (04) :1283-1286
[9]
PARTICULATE SILICONE FOR USE IN PERIURETHRAL INJECTIONS - LOCAL TISSUE EFFECTS AND SEARCH FOR MIGRATION [J].
HENLY, DR ;
BARRETT, DM ;
WEILAND, TL ;
OCONNOR, MK ;
MALIZIA, AA ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1995, 153 (06) :2039-2043
[10]
New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux [J].
Kershen, RT ;
Atala, A .
UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (01) :81-+